14th July — 12:00 UTC (check local time) 

Stephanie Shepheard
Research Associate at the Motor, Neuron Disease and Neurotrophic Lab, Flinders Health & Medical Research Institute, College of Medicine & Public Health, Flinders University, South Australia. Speaking from Adelaide, Australia.

p75 neurotrophin receptor as a biomarker for ALS clinical trials

Treatment development in Amyotrophic Lateral Sclerosis, a fatal neurodegenerative disease with an average life expectancy of 3-5 years, is hindered by the lack of objective biomarkers. In a world first, we have developed neurotrophin receptor p75ECD as a biomarker of disease progression.

11th August — 16:00 UTC (check local time) 

Austin Keeler
Research Associate in Cristopher Deppmann's group at the University of Virginia. Speaking from Charlottesville, Virginia, USA.

Heavy Metal Neuroscience: Neural Single-Cell Mass Cytometry

We adapted single-cell mass cytometry to track neurons and glia across somatosensory development producing the first high throughput, protein-based, high dimensional analysis of a developing neural system.

8th September — 16:00 UTC (check local time) 

Jorge Ruas
Professor of Molecular Physiology at the Department of Physiology and Pharmacology, Karolinska Institutet. Speaking from Stockholm, Sweden.

Muscle-secreted Neurturin couples myofiber and motor neuron function.

Aerobic exercise promotes skeletal muscle vascularization, oxidative metabolism, fiber-type switching, and neuromuscular junction integrity. We show that muscle-secreted neurturin leads to a transcriptional reprogramming of muscle and motor neurons, inducing many of the adaptations to training.

The NGF Webinar Series is an initiative of a group of early-career scientists to keep our field connected during this challenging times and beyond. You can contact us by using the registration form or our social networks.